BR100 Decreased By (-0.6%)
BR30 Decreased By (-0.86%)
KSE100 Decreased By (-0.54%)
KSE30 Decreased By (-0.53%)
AGHA 6.60 Decreased By ▼ -0.07 (-1.05%)
BECO 4.35 No Change ▼ 0.00 (0%)
BML 55.50 Decreased By ▼ -0.67 (-1.19%)
BOP 29.95 Decreased By ▼ -0.17 (-0.56%)
CNERGY 12.80 Decreased By ▼ -0.18 (-1.39%)
CSIL 5.28 Decreased By ▼ -0.03 (-0.56%)
FCCL 51.14 Decreased By ▼ -0.51 (-0.99%)
FFL 14.31 Decreased By ▼ -0.18 (-1.24%)
FNEL 1.20 Decreased By ▼ -0.01 (-0.83%)
KEL 6.04 Decreased By ▼ -0.02 (-0.33%)
KOSM 5.67 Decreased By ▼ -0.17 (-2.91%)
LOTCHEM 26.10 Decreased By ▼ -0.07 (-0.27%)
MLCF 88.98 Decreased By ▼ -2.25 (-2.47%)
NBP 162.48 Decreased By ▼ -1.71 (-1.04%)
NCPL 52.38 Decreased By ▼ -0.80 (-1.5%)
NPL 58.17 Decreased By ▼ -0.95 (-1.61%)
OGDC 312.90 Decreased By ▼ -0.49 (-0.16%)
PACE 9.67 Decreased By ▼ -0.10 (-1.02%)
PAEL 34.94 Decreased By ▼ -0.30 (-0.85%)
PIBTL 14.40 Decreased By ▼ -0.31 (-2.11%)
PPL 218.65 Decreased By ▼ -2.71 (-1.22%)
PRL 91.32 Increased By ▲ 0.10 (0.11%)
PTC 59.02 Decreased By ▼ -0.17 (-0.29%)
SSGC 22.95 Decreased By ▼ -0.35 (-1.5%)
TBL 8.62 Decreased By ▼ -0.13 (-1.49%)
TELE 7.43 Decreased By ▼ -0.18 (-2.37%)
TPL 21.50 Decreased By ▼ -0.53 (-2.41%)
TPLP 12.00 Decreased By ▼ -0.56 (-4.46%)
TREET 21.70 Decreased By ▼ -0.03 (-0.14%)
TRG 55.49 Decreased By ▼ -0.30 (-0.54%)

KARACHI: Federal Minister for Planning, Development and Special Initiatives Asad Umar said on Tuesday that the first locally-processed coronavirus vaccine in Pakistan was nothing short of a revolution, adding that while vaccines were in high demand all over the world, the Chinese-produced ones were "the most preferred" in Pakistan.

He made these remarks while addressing the launch ceremony of the locally processed 'PakVac' vaccine in Islamabad. The PakVac vaccine has been developed by China's state-run pharmaceutical company Cansino and is being brought to Pakistan in a concentrated form, where it is packaged at the National Institute of Health (NIH) in Islamabad. Cansino was the first Chinese vaccine to have undergone clinical trials in Pakistan and was administered to around 18,000 people.

Copyright Business Recorder, 2021

Comments

Comments are closed for this article.